Cargando…
Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas
The present study investigated (i) the relationship between standardised morphometric AgNOR parameters (argyrophilic nucleolar organiser region-associated proteins) and MIB1 growth fraction, and (ii) their correlation with immunohistochemical p53, sex steroid receptor status and histopathological di...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615186/ https://www.ncbi.nlm.nih.gov/pubmed/10391375 http://dx.doi.org/10.1155/1998/760324 |
_version_ | 1782396468474150912 |
---|---|
author | Bànkfalvi, Àgnes Schmitz, Klaus Mock, Tobias Kemper, Mechthild Cubick, Christiane Böcker, Werner |
author_facet | Bànkfalvi, Àgnes Schmitz, Klaus Mock, Tobias Kemper, Mechthild Cubick, Christiane Böcker, Werner |
author_sort | Bànkfalvi, Àgnes |
collection | PubMed |
description | The present study investigated (i) the relationship between standardised morphometric AgNOR parameters (argyrophilic nucleolar organiser region-associated proteins) and MIB1 growth fraction, and (ii) their correlation with immunohistochemical p53, sex steroid receptor status and histopathological differentiation grade in serial paraffin sections from 39 breast carcinomas. Ten sections were double-stained for AgNOR/MIB1. AgNOR parameters correlated significantly with MIB1 growth fraction and p53 protein expression. Significant inverse correlation was found between proliferation markers and oestrogen/progesterone receptor status and histopathological grade. AgNOR expression was significantly higher in cycling (MIB1 positive) tumour cells, than in resting (MIB1 negative) ones, however with exceptions. We conclude, that standardised AgNOR parameters correlate with markers of increased malignant potential in breast carcinomas. However, AgNORs seem to reflect proliferation independent cellular and nucleolar activity of tumour cells, as well. We recommend the use of standardised AgNOR analysis for obtaining sound results in routine paraffin sections. |
format | Online Article Text |
id | pubmed-4615186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1998 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-46151862016-01-12 Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas Bànkfalvi, Àgnes Schmitz, Klaus Mock, Tobias Kemper, Mechthild Cubick, Christiane Böcker, Werner Anal Cell Pathol Other The present study investigated (i) the relationship between standardised morphometric AgNOR parameters (argyrophilic nucleolar organiser region-associated proteins) and MIB1 growth fraction, and (ii) their correlation with immunohistochemical p53, sex steroid receptor status and histopathological differentiation grade in serial paraffin sections from 39 breast carcinomas. Ten sections were double-stained for AgNOR/MIB1. AgNOR parameters correlated significantly with MIB1 growth fraction and p53 protein expression. Significant inverse correlation was found between proliferation markers and oestrogen/progesterone receptor status and histopathological grade. AgNOR expression was significantly higher in cycling (MIB1 positive) tumour cells, than in resting (MIB1 negative) ones, however with exceptions. We conclude, that standardised AgNOR parameters correlate with markers of increased malignant potential in breast carcinomas. However, AgNORs seem to reflect proliferation independent cellular and nucleolar activity of tumour cells, as well. We recommend the use of standardised AgNOR analysis for obtaining sound results in routine paraffin sections. IOS Press 1998 1998-01-01 /pmc/articles/PMC4615186/ /pubmed/10391375 http://dx.doi.org/10.1155/1998/760324 Text en Copyright © 1998 Hindawi Publishing Corporation. |
spellingShingle | Other Bànkfalvi, Àgnes Schmitz, Klaus Mock, Tobias Kemper, Mechthild Cubick, Christiane Böcker, Werner Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas |
title | Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas |
title_full | Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas |
title_fullStr | Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas |
title_full_unstemmed | Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas |
title_short | Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas |
title_sort | relationship between agnor proteins, ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas |
topic | Other |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615186/ https://www.ncbi.nlm.nih.gov/pubmed/10391375 http://dx.doi.org/10.1155/1998/760324 |
work_keys_str_mv | AT bankfalviagnes relationshipbetweenagnorproteinski67antigenp53immunophenotypeanddifferentiationmarkersinarchivalbreastcarcinomas AT schmitzklaus relationshipbetweenagnorproteinski67antigenp53immunophenotypeanddifferentiationmarkersinarchivalbreastcarcinomas AT mocktobias relationshipbetweenagnorproteinski67antigenp53immunophenotypeanddifferentiationmarkersinarchivalbreastcarcinomas AT kempermechthild relationshipbetweenagnorproteinski67antigenp53immunophenotypeanddifferentiationmarkersinarchivalbreastcarcinomas AT cubickchristiane relationshipbetweenagnorproteinski67antigenp53immunophenotypeanddifferentiationmarkersinarchivalbreastcarcinomas AT bockerwerner relationshipbetweenagnorproteinski67antigenp53immunophenotypeanddifferentiationmarkersinarchivalbreastcarcinomas |